Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patient Drug Leaflets Should Consolidate Side Effect Info, Research Suggests

Executive Summary

Patient drug information leaflets that display side effect information in special areas to grab patients' attention may actually make it more difficult for patients to remember essential drug information, a cognition researcher told FDA July 19.

You may also be interested in...



“Cognitively Accessible” Rx Labeling Tested By FDA Risk Cmte. Member Day

"Cognitively accessible" prescription drug labeling could reduce medical errors by as much as 80%, according to a forthcoming study by FDA drug safety advisory committee member Ruth Day, PhD

“Cognitively Accessible” Rx Labeling Tested By FDA Risk Cmte. Member Day

"Cognitively accessible" prescription drug labeling could reduce medical errors by as much as 80%, according to a forthcoming study by FDA drug safety advisory committee member Ruth Day, PhD

FDA Adverse Event Draft Guidance Would Restrict "Well Tolerated" Claims

FDA would restrict the use of nonspecific safety claims such as "well tolerated" under its draft guidance on adverse event labeling.

Related Content

UsernamePublicRestriction

Register

PS036476

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel